1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Bio-engineered Stent Market
2.3. Global Bio-engineered Stent Market, By Material, 2025 (US$ Million)
2.4. Global Bio-engineered Stent Market, By Disease Indication, 2025 (US$ Million)
2.5. Global Bio-engineered Stent Market, By End-user, 2025 (US$ Million)
2.6. Global Bio-engineered Stent Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025
3. Bio-engineered Stent Market: Competitive Analysis
3.1. Market Positioning of Key Bio-engineered Stent Market Vendors
3.2. Strategies Adopted by Bio-engineered Stent Market Vendors
4. Bio-engineered Stent Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Bio-engineered Stent Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Medical-grade Stainless Steel
5.3.2. Cobalt Chromium Alloy
5.3.3. Others (Tantalum, Gold, Nitinol, Polymers)
6. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Coronary Heart Disease
6.3.2. Ischemic Heart Disease
6.3.3. Peripheral Artery Disease
6.3.4. Other Cardiovascular Diseases
7. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Ambulatory Surgical Centers
8. North America Bio-engineered Stent Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
8.3. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
8.4. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
8.5. Bio-engineered Stent Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
8.5.1.1.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
8.5.1.1.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
8.5.1.2.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
8.5.1.2.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
8.5.1.3.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
8.5.1.3.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9. UK and European Union Bio-engineered Stent Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.3. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.4. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5. Bio-engineered Stent Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.1.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.1.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.2.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.2.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.3.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.3.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.4.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.4.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.5.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.5.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
9.5.1.6.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
9.5.1.6.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10. Asia Pacific Bio-engineered Stent Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.3. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.4. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5. Bio-engineered Stent Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.1.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.1.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.2.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.2.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.3.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.3.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.4.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.4.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.5.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.5.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
10.5.1.6.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
10.5.1.6.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
11. Latin America Bio-engineered Stent Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
11.3. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
11.4. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
11.5. Bio-engineered Stent Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
11.5.1.1.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
11.5.1.1.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
11.5.1.2.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
11.5.1.2.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
11.5.1.3.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
11.5.1.3.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
12. Middle East and Africa Bio-engineered Stent Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
12.3. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
12.4. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
12.5. Bio-engineered Stent Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
12.5.1.1.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
12.5.1.1.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
12.5.1.2.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
12.5.1.2.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Bio-engineered Stent Market: By Material, 2024-2034, USD (Million)
12.5.1.3.2. Bio-engineered Stent Market: By Disease Indication, 2024-2034, USD (Million)
12.5.1.3.3. Bio-engineered Stent Market: By End-user, 2024-2034, USD (Million)
13. Company Profile
13.1. ORBUSNEICH MEDICAL (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Medtronic, plc.
13.3. Abbott Laboratories
13.4. Vascular Concepts
13.5. C. R. Bard
13.6. Lombard Medical Technologies
13.7. Biotronik SE & Co. KG
13.8. Terumo Corporation
13.9. Endologix, Inc.
13.10. Translumina GmbH
